Lishan Biotech

Shanghai Lishan Biopharmaceutical Co., Ltd. was founded in 2022, with its headquarters located in Zhangjiang, Shanghai, China. Lishan Biotech precisely integrates global technical resources to build an AI-powered interdisciplinary new drug discovery platform, committed to the continuous development of globally innovative drugs with differentiated competitive advantages. Focusing on the research and discovery of live biotherapeutics targeting inflammatory bowel disease (IBD) and type 2 diabetes mellitus (T2DM) gut microbiota, the company strives to become a leading global enterprise in gut microbiome pharmaceuticals.